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Disruption of the Rev3l-encoded catalytic subunit of polymerase ζ
in mice results in early embryonic lethality
Gloria Esposito*†, Isabelle Godin‡†, Ulf Klein*§, Marie-Laure Yaspo¶,
Ana Cumano¥ and Klaus Rajewsky*
Polymerase ζ (Pol ζ) is an error-prone DNA
polymerase [1], which in yeast is involved in
trans-lesion synthesis (TLS) and is responsible for
most of the ultraviolet (UV) radiation-induced and
spontaneous mutagenesis [2–4]. Pol ζ consists of
three subunits: REV1, a deoxycytidyl-transferase [5];
REV7, of unclear function [6]; and REV3, the catalytic
subunit. REV3 alone is sufficient to carry out TLS, but
association with REV1 and REV7 enhances its activity
[5,7]. Experiments using human cells treated with UV
radiation indicate also that mammalian Pol ζ is
involved in TLS [7]. The peculiar mutagenic activity
of Pol ζ [4,7,8] suggests a possible role in somatic
hypermutation of immunoglobulin (Ig) genes [9].
Here, we report that, unlike in yeast where the
REV3 gene is not essential for life [4], disruption of
the mouse homologue (Rev3l) resulted in early
embryonic lethality. In Rev3l–/– embryos, no
haematopoietic cells other than erythrocytes could be
identified in the yolk sac. Rev3l–/– haematopoietic
precursors were unable to expand in vitro and no
haematopoietic cells could be derived from the
intraembryonic haematogenic compartment
(splanchnopleura). Fibroblasts could not be derived
from the Rev3l–/– embryos, and Rev3l–/– embryonic
stem (ES) cells could not be obtained. This is the first
evidence that an enzyme involved in TLS is critical for
mammalian development.
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Results and discussion
We targeted the 5′ region of the Rev3l gene to avoid the
possibility of generating a truncated Rev3l protein. Two
human REV3 cDNA probes encompassing the 5′ region
of the gene were used to screen a P1 library generated
from C57BL/6 genomic DNA ([10], constructed by
F. Francis and available at http://www.rzp.de). A single
clone (ICRFp703H13126Q6) was isolated and a 25 kb
fragment that hybridised with our 5′ probes was sub-
cloned and sequenced. Sequence comparison with the
human REV3 cDNA sequence in the NCBI-BLAST
database (accession number AF035537) revealed that the
fragment encompassed the four exons of Rev3l that were
located downstream of the translational start site. In our
targeting strategy, we disrupted the reading frame by
inserting a mutation into the first of these four exons.
Recently, the human REV3 locus was characterised, and
it turned out that this targeted exon corresponds to
exon IV of REV3 and is separated from exon III by
approximately 80 kb [11]. 
Bruce-4 ES cells (derived from C57BL/6 mice [12]) were
transfected with a targeting vector that introduced a
neomycin-resistance gene flanked by loxP sites into
exon IV of Rev3l (Figure 1). Three independent Rev3l+/–
ES cell clones (obtained as described in [13,14]) were
used to generate chimeric mice; one of the clones trans-
mitted the targeted allele into the germ line (Figure 1).
When Rev3l+/– mice were intercrossed, no Rev3l–/– mice
could be identified among 125 pups (84 heterozygous and
41 wild type). Thus, Rev3l deficiency causes embryonic
lethality. We cannot exclude the possibility that the
lethality is due to the activity of a truncated Rev3l
polypeptide (see Figure 1). It is, however, unlikely that
such a polypeptide would act in a dominant-negative
fashion as the heterozygous mutants appeared normal. 
As REV3 protein seems to be expressed at very low levels
in mammalian cells ([7] and our own observations), it
appeared possible that Pol ζ-dependent functions would
be impaired in heterozygous mutants. Therefore, following
up on the question of whether Pol ζ is involved in somatic
hypermutation of antibody genes, we studied Rev3l+/–
mice for the level and pattern of somatic mutation as
described in [15]. However, no difference in the fraction
of mutated variable region gene sequences, mutation
frequency and pattern of somatic mutation could be
observed between wild-type and heterozygous mutants
(data not shown).
To circumvent lethality, we tried to generate Rev3l–/– ES
cells to be injected into blastocysts from mice unable to
produce B cells [16]. Following deletion of the loxP-
flanked neomycin gene (see Figure 1) upon transient Cre
transfection [13], the Rev3l+/– ES cells were targeted again.
However, among the 332 clones that were screened, no
double recombinant clones could be recovered despite the
expected high frequency of homologous recombination on
the previously targeted allele (31/332). Thus, Rev3l–/– ES
cells are not viable. Nevertheless, we found that embryos
developed and then died between 8.5 and 10.5 days post
coitum (dpc). Any attempt to derive fibroblast cell lines
from the mutant embryos failed (data not shown).
Eleven litters from heterozygous crossings were examined
between 8.5 and 10.5 dpc. In the 23 Rev3l–/– embryos
found in these litters, a common feature was a decreased
size of the embryo compared with the extraembryonic
compartment. Mutant embryos were classified according
to the severity of the intraembryonic reduction as pheno-
type A, B or C (see Supplementary material). The general
morphology of phenotype A embryos (not shown) was
typical of 8–8.5 dpc embryos, with an apparently normal
development of neural tube and heart and normal extent
of hind gut closure. However, the truncal region was sig-
nificantly reduced, lacking defined somites. In the seven
embryos of phenotype B (Figure 2a,c), the extraembry-
onic compartment was similar in size and morphology to
that of a control 8 dpc embryo (Figure 2d). The intraem-
bryonic compartment of these embryos appeared severely
underdeveloped compared with the extraembryonic com-
partment and was similar in size and morphology to that of
control 7.5 dpc embryos (Figure 2e) [17]. In phenotype C,
which was the most common, the development of the
intraembryonic compartment appeared arrested at the late
primitive streak stage (7.25–7.75 dpc) [17] (Figure 2f,g). In
the most severe case, the embryo body was completely
absent (Figure 2h,i).
For all phenotypes, the extraembryonic structures dis-
played normal development. Although Rev3l–/– yolk sacs
were rarely as well developed as those of their wild-type
and heterozygous littermates, blood islands filled with red
blood cells were present. In most cases, the allantois was
found attached to the ectoplacental cone, an event that
takes place at the six-somite stage (8 dpc) [18]. In pheno-
type C, the allantois and amnion were missing, but yolk
sac development appeared to be less affected: a well-
developed blood vessel network filled with red blood cells
was found in a mutant embryo from a 10–10.5 dpc litter
(Figure 2i). Taken together, Rev3l inactivation leads to a
specific block in the development of the embryo proper,
which never exceeds the early somite stage (8–8.5 dpc).
The overall phenotype of Rev3l–/– embryos appeared com-
parable to androgenetic embryos containing two sperm-
derived genomes [19]. These embryos undergo little
intra-embryonic development, but have well-developed
extraembryonic membranes [20,21]. They display a vari-
able reduction of the embryo body, ranging from its com-
plete absence (similar to Rev3l–/– phenotype C) to 4–6
somite-stage equivalents (similar to Rev3l–/– phenotype A).
The best-developed androgenotes, found up to
10–10.5 dpc, display impairment in somite development
similar to that in Rev3l mutants. These similarities raise
the possibility that Pol ζ participates in imprinting. This
hypothesis is currently under investigation.
The ability of individual Rev3l–/– yolk sac or intraembry-
onic haematogenic sites (splanchnopleura) to produce
haematopoietic progeny was assessed in vitro as described
in [22,23] (see Supplementary material). Although Rev3l–/–
yolk sac cultures had 10-fold fewer cells during the first
days of culture than cultures derived from control littermates,
similar percentages of erythroid cells were obtained. Whereas
normal yolk sac readily produced myeloid cells, cultures
from mutant yolk sac were characterised by the absence of
myeloid derivatives (see Supplementary material). After
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Figure 1
Targeting strategy and identification of germ-
line transmission. Left, the Rev3l locus around
exons 4 and 5 is shown together with the
position of the probe used to detect
homologous recombination following digestion
with EcoRI (E), and the sizes of the expected
bands in the Southern analysis. The neomycin-
resistance gene (neor) is flanked by sequences
encoding loxP sites (triangles). Right, Southern
blot of tail DNA from two littermates derived
from an intercross between a Rev3l male
chimera with a C57BL/6 female mouse.
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7 days in culture, no haematopoietic cells could be recov-
ered from Rev3l–/– yolk sac cultures, in contrast to cultures
of control yolk sac. Rev3l–/– splanchnopleura yielded very
few cells, none of them haematopoietic (data not shown).
The absence of haematogenic activity was observed even
in the best-developed embryo in which the splanchno-
pleura seemed normal and similar to that of five-somite-
stage embryos, which invariably gave rise to haematopoietic
cells in vitro (data not shown). In conclusion, Rev3l defi-
ciency drastically affects haematopoiesis. In the (intraem-
bryonic) splanchnopleura, haematopoietic cells were never
detected. An apparently normal primitive erythroid com-
partment was generated in the yolk sac, but expansion of
either erythromyeloid or committed erythroid precursors
did not occur in vitro.
It is not clear why the Rev3l deficiency leads to embryonic
lethality. It has been suggested that TLS may be essential
at the initial stages of development when a few highly
replicating cells give rise to a variety of tissues [1]. Perhaps
Pol ζ is recruited specifically to replication forks that stall
at DNA lesions; in the absence of Pol ζ, replication may
not be able to continue and the cell undergoes apoptosis.
If this scenario is true, our findings suggest that little or no
cell division is required for primitive erythrocyte genera-
tion in the yolk sac.
The human and murine REV3 cDNAs encode 300 kDa
proteins, which are thus twice as large as their yeast coun-
terpart [4,11,24]. The presence of an additional large
amino-acid region suggests that mammalian REV3 pro-
teins have acquired additional functions and/or more
sophisticated regulatory mechanisms compared with yeast.
The additional region shows no similarity to other known
proteins or functional domains except for the presence of
three potential transmembrane helices, (as predicted by
the SMART program [25]). If REV3 protein has evolved
towards a more complex function, the deficiency of TLS
may not represent the primary or sole cause of lethality in
the mutant mice. Along these lines, it has recently been
suggested that Pol ζ may play a role during DNA inter-
strand cross-link repair [26]. Intriguingly, a Drosophila
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Figure 2
(a–c) Rev3l–/– embryos (9 dpc) showing
phenotype B. (d,e) Control Balb/c embryos at
(d) the six-somite stage shown with the yolk
sac open, and (e) at the late head fold stage
(7.5 dpc). (f–i) Rev3l–/– embryos showing
phenotype C. The embryos are shown with
the anterior to the left, except in (a), which is a
caudal view. (a,d) The size and morphology of
the yolk sac (YS) and allantois (Al) of (a) the
Rev3l–/– embryo were similar to those of
(d) the control embryo. In both cases, the
allantois was connected to the ectoplacental
cone (EPC, arrows). NF, neural folds; H,
heart. (b) The same embryo shown in (a) after
removal of the yolk sac. Because of the
reduction of the embryo body, the amnion
(Am) bulged into the yolk sac cavity and the
allantois appeared extremely long compared
with (e) a control embryo at an equivalent
stage of development. HF, head fold.
(c) Rev3l–/– embryo from a 9–9.5 dpc litter
(16–22 somites). Blood vessels and erythroid
cells were present (arrowheads). (f) Rev3l–/–
embryo recovered at 8 dpc (1–5 somites).
Already at this stage, the yolk sac (YS)
appeared enlarged in comparison to the
embryo body (EB; here, typical of a late
primitive streak stage). (g) Rev3l–/– embryo
from a 9.5 dpc litter (25 somites). The
development of the yolk sac (YS) was similar
to that of the embryos in (a,c), but the
reduction of the embryo body was more
pronounced. (h) Rev3l–/– embryo from a
9–9.5 dpc litter (16–22 somites). The embryo
in (c) also belongs to this litter, emphasising
the individual variations in the severity of the
phenotype. (i) The yolk sac of this mutant
found in a 10–10.5 dpc litter (29–36 somites)
displayed a well-developed circulatory system:
both endothelial and blood cells appeared
normal. In (h,i), the intraembryonic
compartment was missing. The scale bar
represents 0.2 mm.
melanogaster mutant for a DNA polymerase (mus308,
homologous to human Pol θ [27]) involved in DNA cross-
link repair [28] shows increased embryonic mortality. How
any of the known functions of Rev3l can be related to the
similarity of Rev3l-deficient embryos to androgenetic
embryos (see above) remains a mystery.
Despite the large number of novel DNA polymerases [29],
it is noteworthy that Pol ζ has a non-redundant function in
development, in contrast to Pol η, whose function is not
required during embryogenesis, as demonstrated by the
existence of humans carrying two non-functional Pol η
genes [30]. Nevertheless, despite the severe impact of the
Pol ζ deficiency on embryonic development, it is quite
possible that the absence of this enzyme can be tolerated
in the adult, given that some cells do develop in Rev3l-
deficient embryos. We are therefore in the process of gen-
erating a conditional Rev3l mutant to assess the role of
Pol ζ in differentiated cells, including B lymphocytes
undergoing somatic hypermutation.
Supplementary material
Supplementary material including a table showing the number of
progeny of each genotype obtained from Rev3l+/– intercrosses and a
figure showing flow cytometric analysis of the erythromyeloid progeny of
Rev3l–/– yolk sac is available at http://current-biology.com/supmat/sup-
matin.htm.
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